SCHEMBL9007298

SCHEMBL9007298

Nc1ccc2c(c1)=C1C(=S)CC=CC1=CSN=2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6872786 0.56 CASP1 (0.31) —
SCHEMBL6864413 0.53 — —
SCHEMBL29647884 0.48 MAPT (0.36) —
SCHEMBL2730845 0.48 MAPT (0.36) —
SCHEMBL2447989 0.48 MEN1 (0.47) —
SCHEMBL10825617 0.48 MEN1 (0.47) —
SCHEMBL28145470 0.47 MAPT (0.35) —
SCHEMBL29240610 0.45 MAPT (0.45) —
SCHEMBL1577950 0.43 ALDH1A1 (0.48) —
SCHEMBL30406647 0.43 MEN1 (0.89) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0583317-A1 DIBENZOTHIAZEPINTHIONE AS ANTIVIRAL AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-23 — — EP claimed
WO-1992019607-A1 DIBENZOTHIAZEPINTHIONE AS ANTIVIRAL AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1992-11-12 — — WO claimed
US-5589474-A Dibenzothiazepinthione as antiviral agents GLAXO WELLCOME INC. (US) 1996-12-31 — — US disclosed
EP-0583317-A1 DIBENZOTHIAZEPINTHIONE AS ANTIVIRAL AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-23 — — EP disclosed
WO-1992019607-A1 DIBENZOTHIAZEPINTHIONE AS ANTIVIRAL AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1992-11-12 — — WO disclosed
Send feedback